As the core driver of Blue Label’s performance, we assess the growth potential of Cell C and provide our estimates of it’s future debt structure and finance costs. We scrutinize Cell C’s growth strategy and market differentiation and highlight increased risk of disintermediation for BLU’s core SA distribution business.
